McKesson EVP and chief legal officer Michele Lau sells $2.7m in stock

McKesson reported Q4 FY2026 EPS of $11.69, beating estimates of $11.57 by 1.04%, but revenue missed at $92.3 billion versus $101.23 billion expected, an 8.82% shortfall. The article also discloses an insider sale by Executive Vice President and Chief Legal Officer Michele Lau of 3,550 shares for $2.70 million at $761.09 per share under a 10b5-1 plan. Overall tone is mixed, with the EPS beat offset by a material revenue miss.

Analysis

The market is likely treating this as a near-term de-escalation signal, but the bigger implication is a lower risk premium across the whole oil complex if Hormuz traffic normalizes faster than expected. That matters less for crude outright than for implied vol and crack spreads: once headline risk fades, the move in downstream margin expectations can unwind faster than spot, especially for refiners and shippers that had been priced for disruption persistence.

For McKesson, the insider sale is noise relative to the operating signal: a 10b5-1 disposal near current prices does not change the thesis, but it does suggest management is comfortable monetizing into a valuation that already assumes decent execution. The more important read-through is that the earnings mix still supports multiple stability despite revenue volatility, which can keep the stock pinned near fair value unless the market starts to worry about margin quality or slower prescription/pharmacy throughput into the next two quarters.

The contrarian angle is that the consensus may be underestimating how quickly geopolitical premia can be reintroduced if shipping normalization proves partial rather than complete. If traffic restoration is uneven, crude may stay range-bound while insurance, logistics, and tanker names reprice sharply on renewed tail-risk. For MCK, the risk is not the insider sale itself but that a ‘good enough’ quarter plus a flat share price invites passive rotation out of defensives if rates fall and cyclicals reaccelerate, capping upside unless the company re-accelerates top-line growth.

Key Decisions for Investors

• Short oil volatility rather than outright crude: sell near-dated downside protection / call spreads on USO or XLE for 2-6 weeks if shipping headlines continue to normalize; asymmetry favors vol decay over large directional upside absent fresh escalation.
• Long refiners on normalization, but only tactically: buy weak names in VLO/MPC on any post-news pullback for a 1-2 month trade; if crude risk premium collapses faster than product cracks, the rerating can be sharp, but stop out if crack spreads fail to hold within 10 trading days.
• Use MCK as a defensive compounder, not a momentum name: initiate or add on 3-5% dips over the next 1-3 months, targeting low-teens upside if earnings quality stays intact; downside is limited unless margins or reimbursement trends deteriorate.
• Pair trade: long MCK / short a higher-multiple healthcare distributor or services peer for 1-2 quarters; the thesis is valuation compression toward steady cash-flow names while the market re-prices quality and buyback support.
• If geopolitical risk reappears, pivot fast into tanker/shipping optionality: keep a watchlist on shipper names and consider short-dated calls only after confirmation of disrupted transit, because the first leg higher usually happens in days, not weeks.